<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Rumoured_Media_Hype_Regarding_Veliparib</id>
		<title>Rumoured Media Hype Regarding Veliparib - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Rumoured_Media_Hype_Regarding_Veliparib"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Rumoured_Media_Hype_Regarding_Veliparib&amp;action=history"/>
		<updated>2026-05-03T17:10:31Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Rumoured_Media_Hype_Regarding_Veliparib&amp;diff=198841&amp;oldid=prev</id>
		<title>Cell0linda: Створена сторінка: Moises Calderon has received lecture fees from ALK Abello, Horsholm Denmark, a manufacturer of allergy vaccines. &quot;&quot;Studies show that anaphylaxis is under-recogn...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Rumoured_Media_Hype_Regarding_Veliparib&amp;diff=198841&amp;oldid=prev"/>
				<updated>2017-07-07T03:40:26Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Moises Calderon has received lecture fees from ALK Abello, Horsholm Denmark, a manufacturer of allergy vaccines. &amp;quot;&amp;quot;Studies show that anaphylaxis is under-recogn...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Moises Calderon has received lecture fees from ALK Abello, Horsholm Denmark, a manufacturer of allergy vaccines. &amp;quot;&amp;quot;Studies show that anaphylaxis is under-recognized and epinephrine (adrenaline) is under-used by medical personnel as well as patients and their families. This study assesses the knowledge of food-induced anaphylaxis diagnosis and management across different populations of providers and caregivers and other interested respondents. An online survey embedded in a case discussion of food-induced anaphylaxis was distributed by Medscape to registered members. A total of 7822 responders who started the activity chose to answer at least some of the questions presented (response rate 39.5%). Over 80% of responders in all groups correctly identified the case of anaphylaxis with prominent skin and respiratory symptoms; [http://www.selleckchem.com/products/DAPT-GSI-IX.html DAPT in vivo] however, only 55% correctly recognized the case without skin symptoms as anaphylaxis. Only 23% of responders correctly selected risk factors for anaphylaxis, [http://www.selleckchem.com/products/ABT-888.html Veliparib] with physicians significantly more likely to choose the correct answers as compared to allied health, other health professionals, and medical students (p?[https://en.wikipedia.org/wiki/Lazabemide lazabemide] stock epinephrine (adrenaline) (73% vs. 60%, p?&lt;/div&gt;</summary>
		<author><name>Cell0linda</name></author>	</entry>

	</feed>